N-(4-fluorophenyl)indoline-1-carboxamide | 89731-84-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: N-(4-fluorophenyl)indoline-1-carboxamide
• 英文别名: 1H-Indole-1-carboxamide, N-(4-fluorophenyl)-2,3-dihydro-；N-(4-fluorophenyl)-2,3-dihydroindole-1-carboxamide
• CAS: 89731-84-0
• 化学式: C₁₅H₁₃FN₂O
• 分子量: 256.279
• InChiKey: FOZKXJONFQQXRF-UHFFFAOYSA-N

物化性质

• 沸点：
  447.2±45.0 °C(Predicted)
• 密度：
  1.332±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  19
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  32.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  吲哚啉 、 二氧化碳 、 4-氟苯胺 在 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 二甲基亚砜 、 三氟乙酸酐 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 0.42h， 以84%的产率得到N-(4-fluorophenyl)indoline-1-carboxamide
  参考文献：
  名称：

  通过异氰酸酯中间体从CO 2和胺中无金属合成不对称的尿素和氨基甲酸酯

  摘要：

  开发了在CO 2气氛下由芳基胺温和无金属合成芳基异氰酸酯的方法。在DBU存在下，衍生自芳基胺原料和CO 2的氨基甲酸中间体通过活化的reagent试剂脱水，生成相应的异氰酸酯。后者可以通过原位红外检测，并被各种胺和醇捕获，分别制得不对称的脲和氨基甲酸酯。也可以通过相应的二氨基甲酸的温和脱水以高收率制备二氨基甲酸酯。

  DOI：

  10.1021/acs.joc.7b02905

文献信息

• Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such
  申请人：Southern Research Institute

  公开号：US10953017B2

  公开（公告）日：2021-03-23

  Methods for enhancing memory and/or learning and prevent neurodegeneration by administration of certain heterocyclic and aromatic compounds are described. The methods are particularly useful for treating patients suffering from a neurodegenerative disease such as (without limitation) Alzheimer's, Parkinsons's, Lou Gehrig's (ALS) disease or memory or learning impairment. A neuronal human cell-based assay that assess NF-kB gene up-regulation using a luciferase reporter is also provided that screens for compounds useful in methods for enhancing memory or learning.

  本文描述了通过服用某些杂环化合物和芳香族化合物来增强记忆和/或学习能力并防止神经变性的方法。这些方法特别适用于治疗神经退行性疾病患者，如（但不限于）阿尔茨海默氏症、帕金森氏症、卢盖里氏症（ALS）或记忆或学习障碍。此外，还提供了一种基于神经元人体细胞的检测方法，利用荧光素酶报告物评估 NF-kB 基因的上调，从而筛选出在增强记忆或学习能力的方法中有用的化合物。
• TREATMENT OF NEURODEGENERATIVE DISEASES, CAUSATION OF MEMORY ENHANCEMENT, AND ASSAY FOR SCREENING COMPOUNDS FOR SUCH
  申请人：Grimaldi Maurizio

  公开号：US20120245166A1

  公开（公告）日：2012-09-27

  Methods for enhancing memory and/or learning and prevent neurodegeneration by administration of certain heterocyclic and aromatic compounds are described. The methods are particularly useful for treating patients suffering from a neurodegenerative disease such as (without limitation) Alzheimer's, Parkinsons's, Lou Gehrig's (ALS) disease or memory or learning impairment. A neuronal human cell-based assay that assess NF-kB gene up-regulation using a luciferase reporter is also provided that screens for compounds useful in methods for enhancing memory or learning.
• US9095596B2
  申请人：——

  公开号：US9095596B2

  公开（公告）日：2015-08-04
• US9980969B2
  申请人：——

  公开号：US9980969B2

  公开（公告）日：2018-05-29
• [EN] TREATMENT OF NEURODEGENERATIVE DISEASES, CAUSATION OF MEMORY ENHANCEMENT, AND ASSAY FOR SCREENING COMPOUNDS FOR SUCH<br/>[FR] TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES, CAUSE D'AMÉLIORATION DE LA MÉMOIRE ET ANALYSE POUR ÉVALUER DES COMPOSÉS ASSOCIÉS
  申请人：SOUTHERN RES INST

  公开号：WO2011047129A1

  公开（公告）日：2011-04-21

  Methods for enhancing memory and/or learning and prevent neurodegeneration by administration of certain heterocyclic and aromatic compounds are described. The methods are particularly useful for treating patients suffering from a neurodegenerative disease such as (without limitation) Alzheimer's, Parkinsons's, and Lou Gehrig's (ALS) disease or memory or learning impairment. A neuronal human cell-based assay that assess NF-kB gene up-regulation using a luciferase reporter is also provided that screens for compounds useful in methods for enhancing memory or learning.